PubRank

Selma Yüksel

Author PubWeight™ 21.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007 2.09
2 Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 2011 1.80
3 In vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques. J Virol 2010 1.35
4 Measles immune suppression: lessons from the macaque model. PLoS Pathog 2012 1.18
5 DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-lymphocytes. PLoS Pathog 2008 1.15
6 An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity. Vaccine 2004 1.08
7 Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol 2005 1.05
8 Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Virol 2007 0.99
9 Experimental infection of macaques with human metapneumovirus induces transient protective immunity. J Gen Virol 2007 0.97
10 The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation. PLoS Pathog 2010 0.96
11 Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge. Vaccine 2004 0.92
12 Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 2007 0.90
13 Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J Virol 2013 0.90
14 Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies. J Gen Virol 2009 0.87
15 Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets. Vaccine 2012 0.85
16 Measles vaccination of macaques by dry powder inhalation. Vaccine 2006 0.85
17 Measles vaccination of nonhuman primates provides partial protection against infection with canine distemper virus. J Virol 2014 0.85
18 Aerosol measles vaccination in macaques: preclinical studies of immune responses and safety. Vaccine 2006 0.84
19 Specific CD8(+) T-lymphocytes control dissemination of measles virus. Eur J Immunol 2010 0.82
20 Infection of lymphoid tissues in the macaque upper respiratory tract contributes to the emergence of transmissible measles virus. J Gen Virol 2013 0.81
21 Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology. Vaccine 2004 0.80